Liver transplantation acute rejection: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{CMG}}; {{AE}} {{MAD}} {{Liver transplantation}} ==Overview== ==Liver transplantation acute rejection==")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} {{MAD}}
{{CMG}}; {{AE}} {{MAD}}
{{Liver transplantation}}
{{Liver transplantation}}
==Overview==
==Overview==
==Liver transplantation acute rejection==
==Liver transplantation acute rejection==
Early acute cellular rejection mostly occurs within 90 days. [9].
'''Risk factors for acute rejection''' [12-16]:
Recipient prothrombin time or bilirubin that remains steadily elevated
Donors older than 50 years
Donor pre-procurement acidosis
Cytomegalovirus genotype gB1 infection
Fewer human leukocyte antigen (HLA)-DR matches
Cold ischemia time greater than 15 hours
For risk of late rejection, low blood concentration of cyclosporine or tacrolimus. [17] [18].
'''Clinical presentation'''
* Fever, malaise, abdominal pain, and hepatosplenomegaly.
* None of these is specific for rejection.
* Acute cellular rejection is generally suspected based upon the development of hepatic biochemical test abnormalities: [19-21]
Serum aminotransferases
Alkaline phosphatase
Gamma-glutamyl transpeptidase
Bilirubin level
Hepatocyte derived microRNAs (HDmiRs, mir-122, miR-148a) have been evaluated as markers of acute cellular rejection. [32]
'''Liver biopsy'''
* Liver histology is the gold standard for the diagnosis of acute cellular rejection.  [33]
* Presence of biliary strictures and biliary anastomosis with mixed inflammatory infiltrate in the portal triad is sign of rejection.  [34]
* Nonsuppurative cholangitis is important for the prognosis of rejection. The affected ducts are surrounded by immunocytes, which may also be found between epithelial cells, inside the basement membrane, or even in the lumen.
'''Histologic rejection activity index for liver transplants'''
{| class="wikitable"
|'''Category'''
|'''Criteria'''
|'''Score'''
|-
| rowspan="3" |Portal inflammation
|––
|1
|-
|Expansion of most of all of the triads, by a mixed  infiltrate containing lymphocytes with occasional blasts, neutrophils and  eosinophils
|2
|-
|Marked expansion of most or all of the triads by a mixed  infiltrate containing numerous blasts and eosinophils with inflammatory  spillover into the periportal parenchyma
|3
|-
| rowspan="3" |Bile duct inflammation damage
|A minority of the ducts are cuffed and infiltrated by  inflammatory cells and show only mild reactive changes such as increased  nuclear:cytoplasmic ratio of the epithelial cells
|1
|-
|Most or all of the ducts infiltrated by inflammatory  cells. More than an occasional duct shows degenerative changes such as  nuclear pleomorphism, disordered polarity and cytoplasmic vacuolization of  the epithelium
|2
|-
|As above for 2, with most or all of the ducts showing  degenerative changes or focal lumenal disruption
|3
|-
| rowspan="3" |Venous endothelial inflammation
|Subendothelial lymphocytic infiltration involving some,  but not a majority of the portal and/or hepatic venules
|1
|-
|Subendothelial lymphocytic infiltration involving some,  but not a majority of the portal and/or hepatic venules
|2
|-
|As above for 2, with moderate or severe perivenular  inflammation that extends into the perivenular parenchyma and is associated  with perivenular hepatocyte necrosis
|3
|}

Revision as of 15:17, 15 December 2017


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Liver trasnsplantation Microchapters

Home

Patient Information

Overview

Historical Perspective

Indications

Pre-surgical management

Choice of donor

Epidemiology and Demographics

Techniques

Complications

Acute rejection

Immune therapy

Post-surgical infection

Prognosis

Overview

Liver transplantation acute rejection

Early acute cellular rejection mostly occurs within 90 days. [9].

Risk factors for acute rejection [12-16]:

Recipient prothrombin time or bilirubin that remains steadily elevated

Donors older than 50 years

Donor pre-procurement acidosis

Cytomegalovirus genotype gB1 infection

Fewer human leukocyte antigen (HLA)-DR matches

Cold ischemia time greater than 15 hours

For risk of late rejection, low blood concentration of cyclosporine or tacrolimus. [17] [18].

Clinical presentation

  • Fever, malaise, abdominal pain, and hepatosplenomegaly.
  • None of these is specific for rejection.
  • Acute cellular rejection is generally suspected based upon the development of hepatic biochemical test abnormalities: [19-21]

Serum aminotransferases

Alkaline phosphatase

Gamma-glutamyl transpeptidase

Bilirubin level

Hepatocyte derived microRNAs (HDmiRs, mir-122, miR-148a) have been evaluated as markers of acute cellular rejection. [32]

Liver biopsy

  • Liver histology is the gold standard for the diagnosis of acute cellular rejection.  [33]
  • Presence of biliary strictures and biliary anastomosis with mixed inflammatory infiltrate in the portal triad is sign of rejection. [34]
  • Nonsuppurative cholangitis is important for the prognosis of rejection. The affected ducts are surrounded by immunocytes, which may also be found between epithelial cells, inside the basement membrane, or even in the lumen.

Histologic rejection activity index for liver transplants

Category Criteria Score
Portal inflammation –– 1
Expansion of most of all of the triads, by a mixed infiltrate containing lymphocytes with occasional blasts, neutrophils and eosinophils 2
Marked expansion of most or all of the triads by a mixed infiltrate containing numerous blasts and eosinophils with inflammatory spillover into the periportal parenchyma 3
Bile duct inflammation damage A minority of the ducts are cuffed and infiltrated by inflammatory cells and show only mild reactive changes such as increased nuclear:cytoplasmic ratio of the epithelial cells 1
Most or all of the ducts infiltrated by inflammatory cells. More than an occasional duct shows degenerative changes such as nuclear pleomorphism, disordered polarity and cytoplasmic vacuolization of the epithelium 2
As above for 2, with most or all of the ducts showing degenerative changes or focal lumenal disruption 3
Venous endothelial inflammation Subendothelial lymphocytic infiltration involving some, but not a majority of the portal and/or hepatic venules 1
Subendothelial lymphocytic infiltration involving some, but not a majority of the portal and/or hepatic venules 2
As above for 2, with moderate or severe perivenular inflammation that extends into the perivenular parenchyma and is associated with perivenular hepatocyte necrosis 3